Cyclo Therapeutics Inc (CYTH)

[Lazarus]

RE: This technique is PATENTABLE

Of course, I pointed this out in a previous post where I stated:
_________

Since HP-ß-CD has not previously been approved by the FDA as an active ingredient for a therapeutic treatment, it also will not be easily used off-label through a doctor’s prescription. Therefore, the incentives provided by the orphan drug designation to take HP-ß-CD to approval could be significant.


Which you can read about here


WHICH I TAKE TO MEAN THAT WHOEVER GETS THERE FIRST IS GONNA MAKE A LOT OF MONEY.
__________

The money to be made will be in the PATENT AND FDA APPROVAL(S)

THERE'S THE BEEF.

That is why VTESSE has entered into the field. BIG BUCKS AT STAKE and now the race is on.

The question is who is more likely to cross the finish line???? CTDH or VTESSE????

With TEN TIMES THE FUNDING, all those doctors on board, AND A PRESS RELEASE FROM THE NATIONAL INSTITUTE OF HEALTH STATING THEY HAVE TEAMED UP VTESSE TO DEVELOPE TREATMENTS FOR NPD ---->

my bet is VTESSE... unfortunately theY are a private company... otherwise I would buy their stock.

I DONT WANT TO BUY THE SIZZLE I WANT TO BUY THE STEAK!


Between now and September there will be 2 Qs.

Watching and waiting.